google-site-verification: googlec7193c3de77668c9.html
Wednesday , September 9 2026

FDA approves Inqovi for acute myeloid leukemia

[
The U.S. Food and Drug Administration has approved Taiho Oncology’s Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older or who are ineligible for intensive induction chemotherapy.


Source link

Advertisements

See also  Here's the science behind your skeleton

Check Also

More injuries following the policy change of body-checking in women’s ice hockey—but the players are positive

[ Credit: Tima Miroshnichenko from Pexels Four years after body-checking was introduced, have injury rates …

Do I have asthma? All you need to know about symptoms, diagnosis and treatments

[ Asthma is a long-term condition, but there are ways to keep it under good …

Trauma linked to fragmented adolescent conscience

[ Credit: Pixabay/CC0 Public Domain What does it mean when a young person seems to …

Leave a Reply

Available for Amazon Prime